BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 18522868)

  • 21. N-benzoylated phenoxazines and phenothiazines: synthesis, antiproliferative activity, and inhibition of tubulin polymerization.
    Prinz H; Chamasmani B; Vogel K; Böhm KJ; Aicher B; Gerlach M; Günther EG; Amon P; Ivanov I; Müller K
    J Med Chem; 2011 Jun; 54(12):4247-63. PubMed ID: 21563750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design and synthesis of new symmetrical derivatives of dihydropyridine containing a pyridyl group on the 3, 5-positions and evaluation of their cytotoxic and multidrug resistance reversal activity.
    Foroughinia F; Javidnia K; Amirghofran Z; Mehdipour A; Miri R
    J Pharm Pharmacol; 2008 Nov; 60(11):1481-9. PubMed ID: 18957169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and evaluation of nitric oxide-releasing DDB derivatives as potential Pgp-mediated MDR reversal agents in MCF-7/Adr cells.
    Tang X; Gu X; Ai H; Wang G; Peng H; Lai Y; Zhang Y
    Bioorg Med Chem Lett; 2012 Jan; 22(2):801-5. PubMed ID: 22209486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural features determining activity of phenothiazines and related drugs for inhibition of cell growth and reversal of multidrug resistance.
    Ford JM; Prozialeck WC; Hait WN
    Mol Pharmacol; 1989 Jan; 35(1):105-15. PubMed ID: 2563302
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and evaluation of (2-(4-methoxyphenyl)-4-quinolinyl)(2-piperidinyl)methanol (NSC23925) isomers to reverse multidrug resistance in cancer.
    Duan Z; Li X; Huang H; Yuan W; Zheng SL; Liu X; Zhang Z; Choy E; Harmon D; Mankin H; Hornicek F
    J Med Chem; 2012 Apr; 55(7):3113-21. PubMed ID: 22400811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and structure-activity relationships of taxuyunnanine C derivatives as multidrug resistance modulator in MDR cancer cells.
    Hasegawa T; Bai J; Dai J; Bai L; Sakai J; Nishizawa S; Bai Y; Kikuchi M; Abe M; Yamori T; Tomida A; Tsuruo T; Hirose K; Ando M
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3722-8. PubMed ID: 17490878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heterocyclic and phenyl double-bond-locked combretastatin analogues possessing potent apoptosis-inducing activity in HL60 and in MDR cell lines.
    Simoni D; Grisolia G; Giannini G; Roberti M; Rondanin R; Piccagli L; Baruchello R; Rossi M; Romagnoli R; Invidiata FP; Grimaudo S; Jung MK; Hamel E; Gebbia N; Crosta L; Abbadessa V; Di Cristina A; Dusonchet L; Meli M; Tolomeo M
    J Med Chem; 2005 Feb; 48(3):723-36. PubMed ID: 15689156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 2,3-Dihydro-1H,7H-pyrimido[5,6,1-de]acridine-1,3,7-trione derivatives, a class of cytotoxic agents active on multidrug-resistant cell lines: synthesis, biological evaluation, and structure-activity relationships.
    Antonini I; Polucci P; Kelland LR; Menta E; Pescalli N; Martelli S
    J Med Chem; 1999 Jul; 42(14):2535-41. PubMed ID: 10411474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-activity relationships studies in a series of N,N-bis(alkanol)amine aryl esters as P-glycoprotein (Pgp) dependent multidrug resistance (MDR) inhibitors.
    Martelli C; Coronnello M; Dei S; Manetti D; Orlandi F; Scapecchi S; Novella Romanelli M; Salerno M; Mini E; Teodori E
    J Med Chem; 2010 Feb; 53(4):1755-62. PubMed ID: 20104851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and structure-activity relationships of a new series of retinoid-related biphenyl-4-ylacrylic acids endowed with antiproliferative and proapoptotic activity.
    Cincinelli R; Dallavalle S; Nannei R; Carella S; De Zani D; Merlini L; Penco S; Garattini E; Giannini G; Pisano C; Vesci L; Carminati P; Zuco V; Zanchi C; Zunino F
    J Med Chem; 2005 Jul; 48(15):4931-46. PubMed ID: 16033272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 3-(3,4,5-Trimethoxyphenyl)-1-oxo-2-propene: a novel pharmacophore displaying potent multidrug resistance reversal and selective cytotoxicity.
    Das U; Kawase M; Sakagami H; Ideo A; Shimada J; Molnár J; Baráth Z; Bata Z; Dimmock JR
    Bioorg Med Chem; 2007 May; 15(10):3373-80. PubMed ID: 17383883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coumarin derivatives as potential antitumor agents: Growth inhibition, apoptosis induction and multidrug resistance reverting activity.
    Bisi A; Cappadone C; Rampa A; Farruggia G; Sargenti A; Belluti F; Di Martino RMC; Malucelli E; Meluzzi A; Iotti S; Gobbi S
    Eur J Med Chem; 2017 Feb; 127():577-585. PubMed ID: 28109950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis and biological profile of new inhibitors of multidrug resistance associated proteins carrying a polycyclic scaffold.
    Bisi A; Gobbi S; Merolle L; Farruggia G; Belluti F; Rampa A; Molnar J; Malucelli E; Cappadone C
    Eur J Med Chem; 2015 Mar; 92():471-80. PubMed ID: 25596478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New 1,3-dioxolane and 1,3-dioxane derivatives as effective modulators to overcome multidrug resistance.
    Schmidt M; Ungvári J; Glöde J; Dobner B; Langner A
    Bioorg Med Chem; 2007 Mar; 15(6):2283-97. PubMed ID: 17276076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Triphenylmethylamides (TPMAs): Structure-activity relationship of compounds that induce apoptosis in melanoma cells.
    Palchaudhuri R; Hergenrother PJ
    Bioorg Med Chem Lett; 2008 Nov; 18(22):5888-91. PubMed ID: 18710803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design and synthesis of tetrahydroisoquinoline derivatives as potential multidrug resistance reversal agents in cancer.
    Li Y; Zhang HB; Huang WL; Li YM
    Bioorg Med Chem Lett; 2008 Jun; 18(12):3652-5. PubMed ID: 18502125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and biological evaluation of novel cytotoxic azanaphthoquinone annelated pyrrolo oximes.
    Shanab K; Pongprom N; Wulz E; Holzer W; Spreitzer H; Schmidt P; Aicher B; Müller G; Günther E
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6091-5. PubMed ID: 17904839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
    Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH
    Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis of some novel benzofuran-2-yl(4,5-dihyro-3,5-substituted diphenylpyrazol-1-yl) methanones and studies on the antiproliferative effects and reversal of multidrug resistance of human MDR1-gene transfected mouse lymphoma cells in vitro.
    Parekh S; Bhavsar D; Savant M; Thakrar S; Bavishi A; Parmar M; Vala H; Radadiya A; Pandya N; Serly J; Molnár J; Shah A
    Eur J Med Chem; 2011 May; 46(5):1942-8. PubMed ID: 21396744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of cycloartanes on reversal of multidrug resistance and apoptosis induction on mouse lymphoma cells.
    Madureira AM; Spengler G; Molnár A; Varga A; Molnár J; Abreu PM; Ferreira MJ
    Anticancer Res; 2004; 24(2B):859-64. PubMed ID: 15161038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.